Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2021

12.11.2020 | Epidemiology

Potential of using mammography screening appointments to identify high-risk women: cross sectional survey results from the national health interview survey

verfasst von: Anand K. Narayan, Sarah F. Mercaldo, Yasha P. Gupta, Erica T. Warner, Constance D. Lehman, Randy C. Miles

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Mammography screening encounters may represent ideal opportunities to identify high-risk women for risk-based screening. During mammography appointments, radiology practices evaluate breast density and ascertain known breast cancer risk factors. Our purpose was to evaluate the potential for mammographic screening encounters to identify high-risk women by estimating the (1) proportion of high-risk women who report that they have undergone mammographic screening and the (2) proportion of high-risk women who receive recommendations for breast MRI screening.

Methods

Women ages 30–85 without breast cancer histories were included from the 2015 National Health Interview Survey, a nationally representative cross-sectional household survey (response rate 80%). Breast Cancer Risk Assessment Tool was used to determine high-risk (lifetime risk>20%). Among high-risk women, primary outcome was proportion reporting mammography screening, secondary outcome was receipt of a breast MRI recommendation after recent mammogram, accounting for complex survey design.

Results

14,958 women were included. 1.0% were high-risk of whom: 91.9% ever had a mammogram, 68.0% had a mammogram within the last year, 81.5% had a mammogram within the last 2 years. 6.4% were recommended to undergo breast MRI. Among high-risk women, women with dense breast tissue were more likely (OR 496.0, 95%CI 52.6,4674.0) and older women were less likely (OR 0.91, 95%CI 0.84,0.99) to receive recommendations for breast MRI.

Conclusions

Among high-risk women, 92% reported undergoing at least one mammogram in their lives. 94% did not receive recommendations for breast MRI screening and 32% did not have a mammogram within the last year. To identify high-risk women, breast imaging centers should consider determining lifetime breast cancer risk during mammography screening visits.
Literatur
4.
Zurück zum Zitat Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C et al (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879–1886CrossRef Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C et al (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879–1886CrossRef
5.
Zurück zum Zitat Schenker N, Raghunathan TE, Chiu PL, Makuc DM, Zhang G, Cohen AJ (2006) Multiple imputation of missing income data in the National Health Interview Survey. J Am Stat Assoc 101:924–933CrossRef Schenker N, Raghunathan TE, Chiu PL, Makuc DM, Zhang G, Cohen AJ (2006) Multiple imputation of missing income data in the National Health Interview Survey. J Am Stat Assoc 101:924–933CrossRef
7.
Zurück zum Zitat Jiang X, McGuinness JE, Sin M, Silverman T, Kukafka R, Crew KD (2019) Identifying women at high risk for breast cancer using data from the electronic health record compared with self-report. JCO Clin Cancer Inform (3):1–8. https://doi.org/10.1200/CCI.18.00072 Jiang X, McGuinness JE, Sin M, Silverman T, Kukafka R, Crew KD (2019) Identifying women at high risk for breast cancer using data from the electronic health record compared with self-report. JCO Clin Cancer Inform (3):1–8. https://​doi.​org/​10.​1200/​CCI.​18.​00072
17.
20.
Zurück zum Zitat Newman LA (2005 Jan) Breast cancer in African-American women. Oncologist 10(1):1–14CrossRef Newman LA (2005 Jan) Breast cancer in African-American women. Oncologist 10(1):1–14CrossRef
Metadaten
Titel
Potential of using mammography screening appointments to identify high-risk women: cross sectional survey results from the national health interview survey
verfasst von
Anand K. Narayan
Sarah F. Mercaldo
Yasha P. Gupta
Erica T. Warner
Constance D. Lehman
Randy C. Miles
Publikationsdatum
12.11.2020
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2021
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-020-06002-9

Weitere Artikel der Ausgabe 1/2021

Breast Cancer Research and Treatment 1/2021 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.